Details

---

Manufacturer

iNova Pharmaceuticals (Singapore)

Registration number

MAL13085050ACZ 

Content

250 mg anhydrous theophylline

Indication

Relief and prophylaxis of reversible bronchospasm in conditions like asthma, chronic bronchitis, and emphysema

Instruction

• Dosage: Adults take 250 mg orally every 12 hours, may adjust by 125 mg based on clinical response and serum levels (target 10–20 µg/mL); children dosing per weight-based guidelines 

• Administration: Swallow tablets whole with food; do not chew or crush to preserve sustained-release action